Suchergebnisse - "Xu, Binghe"

PubPharm (16)

1

Real-world treatment patterns and outcomes of pyrotinib-based therapy in patients with HER2-positive advanced breast cancer (PRETTY) : A nationwide, prospective, observational study

enthalten in: International journal of cancer | 2023

von Li, Y. | Tong, Z. | Wu, X. | +13

2

The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 status

enthalten in: International journal of cancer | 2023

von Jiang, M. | Liu, J. | Li, Q. | +1

3

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer

enthalten in: The New England journal of medicine | 2022

von Cortés, J. | Kim, S. | Chung, W. | +122

CommentIn: Nat Rev Clin Oncol. 2022 May;19(5):283. - PMID 35361895

4

Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice

enthalten in: Clinical breast cancer | 2021

von Chen, X. | Wang, J. | Fan, Y. | +9

5

Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China

enthalten in: Cancer communications (London, England) | 2020

von Yi, Z. | Ma, F. | Rong, G. | +3

6

Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab : A Randomized, Phase II Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Ma, F. | Ouyang, Q. | Li, W. | +11

7

Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer

enthalten in: Anti-cancer drugs | 2019

von Luo, Y. | Li, W. | Jiang, Z. | +13

8

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients : A Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, Q. | Guan, X. | Chen, S. | +16

9

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients

enthalten in: Journal of the National Cancer Institute | 2019

von Lambertini, M. | Campbell, C. | Bines, J. | +19

CommentIn: J Natl Cancer Inst. 2019 Jan 1;111(1):9-10. - PMID 29878141

10

Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1

enthalten in: Breast cancer research : BCR | 2017

von Toi, M. | Shao, Z. | Hurvitz, S. | +13